These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2779523)
1. Purification and characterization of a mouse liver cytochrome P-450 induced by cannabidiol. Bornheim LM; Correia MA Mol Pharmacol; 1989 Sep; 36(3):377-83. PubMed ID: 2779523 [TBL] [Abstract][Full Text] [Related]
2. Selective inactivation of mouse liver cytochrome P-450IIIA by cannabidiol. Bornheim LM; Correia MA Mol Pharmacol; 1990 Sep; 38(3):319-26. PubMed ID: 2402224 [TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily. Bornheim LM; Correia MA Mol Pharmacol; 1991 Aug; 40(2):228-34. PubMed ID: 1875910 [TBL] [Abstract][Full Text] [Related]
4. Effect of cannabidiol on cytochrome P-450 isozymes. Bornheim LM; Correia MA Biochem Pharmacol; 1989 Sep; 38(17):2789-94. PubMed ID: 2550010 [TBL] [Abstract][Full Text] [Related]
5. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver. Riddick DS; Park SS; Gelboin HV; Marks GS Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472 [TBL] [Abstract][Full Text] [Related]
6. A major phenobarbital-inducible P450 isozyme, CYP2A14, in the Chinese hamster liver: purification, characterization, and cDNA cloning. Fukuhara M; Kurose K; Aiba N; Matsunaga N; Omata W; Kato K; Kimura M Arch Biochem Biophys; 1998 Nov; 359(2):241-8. PubMed ID: 9808766 [TBL] [Abstract][Full Text] [Related]
7. Mechanism for inhibitory effect of cannabidiol on microsomal testosterone oxidation in male rat liver. Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H Drug Metab Dispos; 1988; 16(6):880-9. PubMed ID: 2907469 [TBL] [Abstract][Full Text] [Related]
8. Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6. Ohmori S; Shirakawa C; Motohashi K; Yoshida H; Abe H; Nakamura T; Horie T; Kitagawa H; Asaoka K; Rikihisa T Mol Pharmacol; 1993 Feb; 43(2):183-90. PubMed ID: 8429823 [TBL] [Abstract][Full Text] [Related]
9. Cytochrome P-450 isozymes 2 and 5 in rabbit lung and liver. Comparisons of structure and inducibility. Parandoosh Z; Fujita VS; Coon MJ; Philpot RM Drug Metab Dispos; 1987; 15(1):59-67. PubMed ID: 2881760 [TBL] [Abstract][Full Text] [Related]
10. Selective inactivation by chloramphenicol of the major phenobarbital-inducible isozyme of dog liver cytochrome P-450. Ciaccio PJ; Duignan DB; Halpert JR Drug Metab Dispos; 1987; 15(6):852-6. PubMed ID: 2893713 [TBL] [Abstract][Full Text] [Related]
11. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol. Borys HK; Ingall GB; Karler R Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524 [TBL] [Abstract][Full Text] [Related]
12. Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse. Honkakoski P; Lang MA Arch Biochem Biophys; 1989 Aug; 273(1):42-57. PubMed ID: 2502947 [TBL] [Abstract][Full Text] [Related]
13. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats. Jeffery EH; Mannering GJ Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917 [TBL] [Abstract][Full Text] [Related]
14. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs. Stevens JC; Halpert J Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome P-450 isozyme 1 from phenobarbital-induced rat liver: purification, characterization, and interactions with metyrapone and cytochrome b5. Waxman DJ; Walsh C Biochemistry; 1983 Sep; 22(20):4846-55. PubMed ID: 6626536 [TBL] [Abstract][Full Text] [Related]
16. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat. List A; Nazar B; Nyquist S; Harclerode J Drug Metab Dispos; 1977; 5(3):268-72. PubMed ID: 17525 [TBL] [Abstract][Full Text] [Related]
17. Purification of liver microsomal cytochrome P-450 isozymes 3a and 6 from imidazole-treated rabbits. Evidence for the identity of isozyme 3a with the form obtained by ethanol treatment. Koop DR; Coon MJ Mol Pharmacol; 1984 May; 25(3):494-501. PubMed ID: 6427601 [TBL] [Abstract][Full Text] [Related]
18. Mechanism-based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene. Lehman-McKeeman LD; Johnson DR; Caudill D; Stuard SB Drug Metab Dispos; 1997 Mar; 25(3):384-9. PubMed ID: 9172959 [TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a cytochrome P-450 from insecticide susceptible and resistant strains of housefly, Musca domestica L., before and after phenobarbital exposure. Scott JG; Lee SS Arch Insect Biochem Physiol; 1993; 24(1):1-19. PubMed ID: 8374162 [TBL] [Abstract][Full Text] [Related]
20. Interaction of cotinine with rat hepatic microsomal P-450. Comparison with metyrapone and immunomodulation of cotinine and metyrapone binding by monoclonal anti-cotinine antibodies. Bjercke RJ; Hammond DK; Strobel HW; Langone JJ Drug Metab Dispos; 1990; 18(5):759-64. PubMed ID: 1981733 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]